About ICI
Our Global Purpose
Insight Connection International 2000 Ltd. (ICI) is a renowned firm specializing in transforming visionary ideas into reality for purpose-driven organizations and governments. With expertise in strategy and management consulting, we cater to clients operating in various sectors such as medical, cyber security, defense, energy projects, and other government-driven fields.
Our Global Network
At ICI, our clientele encompasses a diverse range of stakeholders, including state leaders, corporate executives, and financial investors. Through our extensive experience working with such clients and projects, we have gained deep-sector expertise and unique insights into the complex dynamics of today’s global challenges. This positions us well to understand and articulate the specific challenges and opportunities faced by our clients, empowering them with effective solutions and a clear vision for success.
Your Resource for Expansion
At ICI, we are dedicated to making a positive impact and driving meaningful change. Our commitment to excellence, combined with our extensive expertise and track record of success, makes us a trusted partner for organizations and governments seeking innovative solutions in their respective fields.
ICI Medical
Pandemic Responce
Within the medical field, ICI has played a significant role in numerous large-scale governmental projects in Africa. One notable initiative involved establishing a network of umbrella clinics to combat HIV/AIDS and address women abuse. This project, conducted in collaboration with the Catholic Church, included the establishment of field clinics in the Democratic Republic of Congo (DRC) and various other endeavors.
ICI Medical
ICI’s COVID-19 solutions
Insight Connection International (ICI) was a key player in the fight against COVID-19, collaborating closely with renowned medical manufacturing companies to provide effective solutions. Partnerships were established with Zug Medical Equipment, a French manufacturer of vital signs monitors and ventilators; AMBISEA Technology Corp., a leading supplier of personal protection materials and medical equipment worldwide; Rare Biotechnology, a Chinese BioMed company specializing in diagnostics for infectious diseases; Nanjing Vazyme Medical Technology Co. Ltd., a reputable manufacturer of reagents and Rapid Serology testing for various diseases, and others.
Throughout the course of the COVID-19 pandemic, ICI successfully supplied their range of COVID-19 related products to numerous regions worldwide, including Europe, East Europe, Africa, the Middle East, Central and South America.
In response to customer and medical colleagues' requests, ICI developed a comprehensive algorithm and strategy for more accurate testing of both symptomatic and asymptomatic populations. This approach involved the utilization of rapid serology and molecular tests, and the company actively worked towards implementing this strategy in several countries, including Israel, The Netherlands, Honduras, Panama, Costa Rica, and the African Union Tourism Organization.
ICI meticulously selected the best kits available in the market, taking into consideration factors such as accuracy, validation with a significant number of patients, certifications, and more. The company's COVID-19 product pipeline consisted of a range of high-quality medical-grade products and certified medical equipment. These offerings included rapid serology and molecular kits, monitors, ventilators, field hospitals, temperature helmets, and personal protective equipment.
